-
If HIV-1 drug resistance is found in a womans plasma, its likely the same resistance is present in her genital tract, suggesting that drug resistance among pregnant, HIV-infected women, requires further investigation, a new study shows.
-
There is new hope for a cost-efficient treatment for HIV-1 infected patients who no longer respond to protease inhibitor (PI) treatment due to multidrug resistance.
-
Two separate studies have found that some types of HIV drug resistance have declined or leveled off at the same time others have increased.
-
While clinicians and researchers are seeing increasing numbers of HIV patients with multidrug-resistant virus, there are indications that some existing drug combinations continue to be potent against resistant virus.
-
Two potential candidates in the microbicide research pipeline are set to be examined in clinical trials, with research to focus on the safety and acceptability in healthy women and women infected with HIV.
-
No one is worried that a financially strapped federal government might kill Ryan White Care Act funding, but AIDS advocates say they are concerned about what will happen with the bill in a slightly different political environment this year.
-
A new study finds that 60% of HIV patients on stable therapy with detectable viral replication have a rate of new HIV mutations of about 1.5 mutations per year.
-
-
Following our inclusion of an article on the role of patients spirituality in their medical care, we received a letter from Chaplain Steve Pyle, director of pastoral care at Baxter Regional Medical Center in Mountain Home, AR. Chaplain Pyle made some insightful comments about our article and included suggestions that we intend to incorporate into future articles on the topic of patients beliefs and their health care.
-
